Om Dignitana AB (publ) Dignitana AB är världsledande inom kliniskt överlägsen skalpkylningsteknologi. Företaget tillverkar DigniCap® Scalp Cooling System, ett patenterat medicinskt skalpkylningssystem som ger cancerpatienter möjlighet att minimera håravfall under cytostatikabehandling.

“Through the DigniCap® App, breast cancer patients interested in using the DigniCap® scalp cooling system at medical centers across the U.S.

Dignitana AB, manufacturer of The DigniCap® Scalp Cooling System, has announced installation of the first DigniCap Delta at the prestigious Gemelli University Hospital in Rome, Italy last month. “This installation is the culmination of extensive research and development efforts and we are eager to expand the global footprint of Dignitana with this innovative technology,” said William First deliveries planned for October (http://www.dignitana.se/)Dignitana AB, world leader in scalp cooling innovation, today announced that the Therapeutic Goo Lund, Sweden – July 3, 2017— Dignitana AB, a world leader in medical scalp cooling technology and manufacturer of the DigniCap® Scalp Cooling System, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to expand use of its medical device to patients in the United States receiving chemotherapy for solid tumor cancers. Donna Tookes was able to keep her hair during breast cancer treatment due to a scalp cooling system called DigniCap. 'Cooling Cap' Allows Patients To Keep Hair During Chemotherapy May 31, 2015 02:52 2020-05-28 In 2015, after a rigorous review by the FDA, DigniCap was the first scalp cooling system to receive clearance in the United States. Summary It was concluded that the DigniCap Scalp Cooling System prevented hair loss in 66.3% of patients with breast cancer receiving adjuvant chemotherapy, compared to a control group where all patients experienced significant hair loss. The FDA cleared DigniCap® Scalp Cooling System minimizes hair loss from certain chemotherapy treatments. DigniCap offre il trattamento del cuoio capelluto per ridurre la caduta dei capelli causata dalla chemioterapia.

In 2015, DigniCap became the first scalp cooling device to receive FDA clearance. After an extensive review of worldwide studies, in 2017 the FDA expanded the clinical indication for DigniCap to include men and women with solid tumors. DigniCap Delta, the next generation of The DigniCap Scalp Cooling System, was FDA cleared in June 2019. About Dignitana. Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l.

Dignitana AB, world leader in medical scalp cooling technology, announced today that the United States Food and Drug Administration has cleared DigniCap Delta® for use by U.S. health care providers. The new device is the fourth generation of The DigniCap® Scalp Cooling System and is indicated to prevent chemotherapy-induced hair loss in patients with solid tumors.

in Italy. The company develops, produces and markets The DigniCap® Scalp Cooling System.

Next generation device of this clinically superior system minimizes hair loss in cancer patients Dignitana AB

Dignitana expands agreement with GenesisCare to include United States. Dignitana AB, global leader in scalp cooling innovation, announced today an agreement signed with GenesisCare to expand their preferred provider network for DigniCap scalp cooling systems to include GenesisCare locations in the United States.

the dignicap scalp cooling system DigniCap offers patients the ability to reduce hair loss from certain chemotherapy treatments and is FDA cleared for patients with solid tumors. The DigniCap Scalp Cooling System consists of a computerized cooling unit managed through a touch screen display and an attached cooling cap. The FDA cleared DigniCap® Scalp Cooling System minimizes hair loss from certain chemotherapy treatments. Cold Cap therapy can reduce chemotherapy-induced hair loss. DigniCap Scalp Cooling System innehåller ett antal funktioner och tekniska framsteg som kombinerar för att förbättra patientens upplevelse.
Föra över bilder från iphone till dator

DigniCap Delta consists of a thermoelectric cooling unit with a computerized control system operated via a touchscreen monitor. An adjustable Cooling Wrap is connected to the cooling unit. DeltaCool coolant is circulated from the device through the Therapy Hose to small channels within the Cooling Wrap. Donna Tookes was able to keep her hair during breast cancer treatment due to a scalp cooling system called DigniCap.

"DigniCap Delta changes everything about the way scalp cooling is done today," said William Cronin, CEO of Dignitana."In the value-based U.S. health care system providers tell us they want to improve the clinical process, reduce nursing intervention and optimize patient outcomes. Next generation device of this clinically superior system minimizes hair loss in cancer patients Dignitana AB (http://www.dignitana.se/), manufacturer of The Di Dignitana AB, världsledande inom medicinteknik för nedkylning av hårbottnen, meddelade idag att USA:s livsmedels- och läkemedelsmyndighet, United States Food and Drug Administration (FDA), har godkänt att DigniCap Delta® används av amerikanska vårdgivare. Den nya produkten är den fjärde generationen av DigniCap® Scalp Cooling System, ett medicinskt skalpkylningssystem som används Det är Dignitana policy att endast patienter som har lämnat samtycke och betalats för behandling får tillåtas använda DigniCap Scalp Cooling System. Som ett alternativ till betalning online kan patienter kontakta patientsupportcentralen vid (877) 350-2150 eller support@dignicap.com att få samtycksdokumenten via e-post, sedan skicka tillbaka signerade samtyckeformulär och en check för The Dignitana DigniCap™ Scalp Cooling System consists of a computer controlled system that includes a refrigerated tank containing the cooling agent that is maintained at -8 ± 1 oC.
Pfas dricksvatten stockholm

yrkesutbildning linkoping
blecktornsstigen 26
evidensbaserad omvårdnad en bro mellan forskning och klinisk verksamhet
vad ska studiebidraget räcka till konsumentverket
skapa snygga nyhetsbrev
parkering korsning enkelriktat
congestion charges cause the price of driving to

The DigniCap Scalp Cooling System consists of a computerized cooling unit managed through a touch screen display and an attached cooling cap with integrated sensors. Temperature-regulated coolant continuously circulates through specially designed channels in the cooling caps.

Temperature-regulated coolant continuously circulates through specially designed channels in the cooling caps. The DigniCap Scalp Cooling System minimizes hair loss from chemotherapy. Dignitana 10925 Estate Lane, Suite 185 Dallas, TX 75238 +1 877-350-2150. HEADQUARTERS Det är Dignitana policy att endast patienter som har lämnat samtycke och betalats för behandling får tillåtas använda DigniCap Scalp Cooling System. Som ett alternativ till betalning online kan patienter kontakta patientsupportcentralen vid (877) 350-2150 eller support@dignicap.com att få samtycksdokumenten via e-post, sedan skicka tillbaka signerade samtyckeformulär och en check för "DigniCap Delta changes everything about the way scalp cooling is done today," said William Cronin, CEO of Dignitana."In the value-based U.S. health care system providers tell us they want to KLICKA HÄR för att ladda ner de tekniska specifikationerna för C3-modellen för DigniCap Scalp Cooling System. Observera att innehållet på denna webbplats inte är avsedd som professionell medicinsk eller hälsovårdlig rådgivning och inte ska tolkas som ersättare för professionell hälsovård eller rådgivning från en kvalificerad professionell vårdgivare som är bekant med din About Us. Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy.

Om Dignitana AB (publ) Dignitana AB är världsledande inom kliniskt överlägsen skalpkylningsteknologi. Företaget tillverkar DigniCap® Scalp Cooling System, ett patenterat medicinskt skalpkylningssystem som ger cancerpatienter möjlighet att minimera håravfall under cytostatikabehandling.

Temperature-regulated coolant continuously circulates through specially designed channels in the cooling caps. DigniCap Delta consists of a thermoelectric cooling unit with a computerized control system operated via a touchscreen monitor. An adjustable Cooling Wrap is connected to the cooling unit. DeltaCool coolant is circulated from the device through the Therapy Hose to small channels within the Cooling Wrap. Donna Tookes was able to keep her hair during breast cancer treatment due to a scalp cooling system called DigniCap. 'Cooling Cap' Allows Patients To Keep Hair During Chemotherapy May 31, 2015 02:52 In 2015, after a rigorous review by the FDA, DigniCap was the first scalp cooling system to receive clearance in the United States. Summary It was concluded that the DigniCap Scalp Cooling System prevented hair loss in 66.3% of patients with breast cancer receiving adjuvant chemotherapy, compared to a control group where all patients experienced significant hair loss.